BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9458291)

  • 1. c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis.
    Schneider J; Jimenez E; Rodriguez F; del Tanago JG
    Oncol Rep; 1998; 5(1):49-52. PubMed ID: 9458291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
    Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
    Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of p53, c-myc and nm23 protein expression in recurrent laryngeal carcinoma].
    Guo R; Huang D; Yang W; Han D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Mar; 17(3):161-3. PubMed ID: 12815897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical study of p53, c-erbB-2 and nm23 proteins in human gastric cancer].
    Wei Z; Wu Y; Zhai Z
    Zhonghua Zhong Liu Za Zhi; 1997 Sep; 19(5):378-81. PubMed ID: 10920922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
    MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
    Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
    Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
    Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunohistochemical analysis of c-erB-2 and nm23 expression in early gastric carcinoma].
    Aoyagi K; Koufuji K; Kodama I; Ohta J; Takamiya H; Mizutani K; Takeda J; Shirouzu K
    Nihon Shokakibyo Gakkai Zasshi; 1996 Sep; 93(9):613-9. PubMed ID: 8965386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
    Ambros RA; Vigna PA; Figge J; Kallakury BV; Mastrangelo A; Eastman AY; Malfetano J; Figge HL; Ross JS
    Cancer; 1994 Mar; 73(6):1686-92. PubMed ID: 8156496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma.
    Schneider J; Centeno M; Jimenez E; Rodriguez-Escudero FJ; Romero H
    Anticancer Res; 1997; 17(3C):2147-51. PubMed ID: 9216679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters.
    Sirotkovic-Skerlev M; Krizanac S; Kapitanovic S; Husnjak K; Unusic J; Pavelic K
    Exp Mol Pathol; 2005 Aug; 79(1):42-50. PubMed ID: 16005711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nm23 expression in advanced and borderline ovarian carcinoma.
    Schneider J; Romero H; Ruiz R; Centeno MM; Rodriguez-Escudero FJ
    Anticancer Res; 1996; 16(3A):1197-202. PubMed ID: 8702236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on C-erbB2, nm23 and p53 expressions in epithelial ovarian cancer and their clinical significance].
    Liu L; Yang K
    Zhonghua Fu Chan Ke Za Zhi; 1999 Feb; 34(2):101-4. PubMed ID: 11263193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and tumour suppressor genes in first trimester human fetal gonadal development.
    Quenby SM; Gazvani MR; Brazeau C; Neilson J; Lewis-Jones DI; Vince G
    Mol Hum Reprod; 1999 Aug; 5(8):737-41. PubMed ID: 10421801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the c-erb B-2, nm23, bcl-2 and p53 protein markers on colorectal cancer.
    Demirbaş S; Sücüllü I; Yildirim S; Celenk T
    Turk J Gastroenterol; 2006 Mar; 17(1):13-9. PubMed ID: 16830272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of nm23-H1 and p53 protein in nasopharyngeal carcinoma].
    Zhou Y; Xu A; Ling X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1998 Jun; 12(6):243-6. PubMed ID: 11189166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of pituitary adenoma invasiveness: a review.
    Suhardja A; Kovacs K; Rutka J
    J Neurooncol; 2001 May; 52(3):195-204. PubMed ID: 11519849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.